Bryan Love to Hepatitis C, Chronic
This is a "connection" page, showing publications Bryan Love has written about Hepatitis C, Chronic.
Connection Strength
1.002
-
Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses. J Manag Care Spec Pharm. 2020 Jul; 26(7):879-886.
Score: 0.625
-
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019 12; 39(12):1190-1203.
Score: 0.149
-
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2016 Feb; 36(2):203-17.
Score: 0.115
-
The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy. Expert Opin Drug Saf. 2015; 14(11):1649-52.
Score: 0.112